Examples include the pursuit of modifying the splicing of apolipoprotein B (APOB) pre-mRNA to lower circulating cholesterol levels and of survival of motor neuron 2 (SMN2) pre-mRNA for treatment of spinal muscular atrophy [6]. This evidence concerns the gene APOB and proximal spinal muscular atrophy.